Global /South Korea /Healthcare /Drug Manufacturers - General /000520

Samil Pharmaceutical Co.,Ltd

000520

• KRX: 000520 • Delayed

8,950KRW -1.7%

5.86 USD

As of 13 June 2026, Samil Pharmaceutical Co.,Ltd has a market cap of $127.03M USD, ranking #23927 globally and #1076 in South Korea. It ranks #2146 in the Healthcare sector, and #779 in the Drug Manufacturers - General industry.

Global Rank

23927

Country Rank

1076

Sector Rank

2146

Industry Rank

779

Key Stats

Market Cap

$127.03MUSD

193.19B KRW

Enterprise Value

$229.85MUSD

350.8B KRW

Revenue (TTM)

$138.25MUSD

210.25B KRW

EBITDA (TTM)

-$9.66MUSD

-14.74B KRW

Net Income (TTM)

-$22.79MUSD

-34.66B KRW

EBITDA Margin

-7%

Profit Margin

-16%

PS Ratio

0.9

PB Ratio

1.4

Company Profile

Country (HQ)

South Korea

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Seung Bum Huh open_in_new

Employees

583

Founded

1947

Website

samil-pharm.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-1.7%	-6.2%	-9.2%	-7.1%	-8%	-6.1%	-29%	17%	3%

News

Markets

Exchange	Ticker	Price	Quotes
Korea Exchange (KRX) MIC: XKRX PRIMARY	000520 삼일제약(주) ISIN: KR7000520007 Shares Out.: Shares Outstanding: 21.371M¹ Shares Float: 15.291M² TV: TradingView: KRX: 000520 SA: Stock Analysis: KRX: 000520 YF: Yahoo Finance: 000520.KS GF: Google Finance: KRX: 000520 BA: Barron's: 000520 MS: Morningstar: XKRX: 000520	8,950 KRW	TV: TradingView: KRX: 000520 SA: Stock Analysis: KRX: 000520 YF: Yahoo Finance: 000520.KS GF: Google Finance: KRX: 000520 BA: Barron's: 000520 MS: Morningstar: XKRX: 000520

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Samil Pharmaceutical Co.,Ltd

Samil Pharmaceutical Co.,Ltd engages in the manufacture and sale of pharmaceuticals in South Korea. It offers general medicines, including Tiersil Once, EYE2O mini eye drops, and Optagent ophthalmic drops; medical devices; secret spotpatch quasi-drugs, and roll away products. The company also provides specialty medicines, such as Hycell solutions; Curelen, Ocufridine, Ocumetholone, Ocucyclo, Ocuhomapine, Ocucarpine, Allerfen, Optanac, Forus, Eymox, Cifex, and Ocuracin ophthalmic drops; and Herpecid, Forus, and Ocurasin ophthalmic ointments. Samil Pharmaceutical Co.,Ltd was founded in 1947 and is headquartered in Seoul, South Korea.

Similar Companies

Industry: Drug Manufacturers - General (South Korea)

Name	Market Cap (USD) diff.	PE	Country
Samsung Epis Holdings Co., Ltd. KRX: 0126Z0	$9.15B 13.91T KRW 7K%	-	South Korea
Sam Chun Dang Pharm. Co., Ltd. KRX: 000250	$6.77B 10.3T KRW 5K%	1958.1	South Korea
SK Biopharmaceuticals Co., Ltd. KRX: 326030	$5.24B 7.97T KRW 4K%	29.9	South Korea
ABL Bio Inc. KRX: 298380	$4.96B 7.55T KRW 4K%	-	South Korea
Yuhan Corp. KRX: 000100	$4.55B 6.92T KRW 3K%	35.9	South Korea
LigaChem Biosciences Inc. KRX: 141080	$4.44B 6.76T KRW 3K%	-	South Korea

Industry: Drug Manufacturers - General (Global)

Name	Market Cap (USD) diff.	PE	Country
Eli Lilly and Co. NYSE: LLY	$761.68B 600K%	38.1	United States
Johnson & Johnson NYSE: JNJ	$547.28B 431K%	26.4	United States
AbbVie Inc. NYSE: ABBV	$360.63B 284K%	97.4	United States
Roche Holding AG SIX: RO	$321.52B 256.25B CHF 253K%	19.9	Switzerland
AstraZeneca PLC LSE: AZN	$288.84B 215.59B GBP 227K%	27.6	United Kingdom
Novartis AG SIX: NOVN	$274.65B 218.9B CHF 216K%	20.5	Switzerland

chevron_leftBack